Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
UNC Lineberger Comprehensive Cancer Center
MedImmune LLC
SWOG Cancer Research Network
The Royal Wolverhampton Hospitals NHS Trust
University of California, San Francisco
University of Washington
University of North Carolina, Chapel Hill
Eli Lilly and Company
Freenome Holdings Inc.